Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Intercure Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 18 | 21 | +3 |
| Shares | 6.58M | 4.85M | −1.73M (−26.3%) |
| Value | $38.1M | $21.9M | −$16.3M (−42.7%) |
New holders (8)
Institutions that held Intercure Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambria Investment Management, L.P. | 62,966 | $284.0K | 0.03% |
| Balyasny Asset Management LLC | 51,576 | $233.0K | 0.00% |
| ExodusPoint Capital Management, LP | 48,089 | $216.0K | 0.00% |
| Geode Capital Management, LLC | 14,148 | $63.0K | 0.00% |
| BlackRock Inc. | 12,959 | $58.0K | 0.00% |
| Bank of America Corp | 566 | $3.00K | 0.00% |
| Citigroup Inc | 36 | $0 | 0.00% |
| Royal Bank of Canada | 92 | $0 | 0.00% |
Sold out (5)
Institutions that held Intercure Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Cohanzick Management, LLC | 128,525 | $748.0K |
| RiverPark Advisors, LLC | 58,743 | $340.0K |
| Penserra Capital Management LLC | 2,929 | $16.0K |
| Banque Cantonale Vaudoise | 2,247 | $13.0K |
| Toronto Dominion Bank | 49 | $0 |